Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

1.1K
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
1.1K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

2.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
Dialysis01:15

Dialysis

2.1K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.1K
Dialysis01:27

Dialysis

2.1K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
2.1K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

4.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

374
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
374

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Bibliometric Analysis of Publications in Uremic Toxins From 1991 to 2024.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·2026
Same author

Effect of the ultrafiltration rate on solute removal efficiency in pre-dilution on-line hemodiafiltration.

The International journal of artificial organs·2026
Same author

Toward a Peritoneal Dialysis-First Policy in the United Kingdom and Europe: A Phenotype-Based Analysis of Survival and System-Level Implications.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Effects of Hemodiafiltration Versus Hemodialysis on Uremic Toxins, Inflammatory Markers, Anemia, and Nutritional Parameters: A Systematic Review and Meta-Analysis.

Toxins·2026
Same author

Dialysis Research at Crossroads of Immigration Policy.

Journal of immigrant and minority health·2026
Same author

Meta-analyses overgeneralize SGLT2 inhibitor effectiveness in population with low albuminuria, no diabetes, no heart failure and no atherovascular heart disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Related Experiment Video

Updated: Apr 28, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K

Membrane-to-Patient Optimization: Individualized Dialyzer Selection for Extracorporeal Dialysis.

Mariana Murea1, Alaa S Awad2, Vandana D Niyyar3

  • 1Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.

Toxins
|April 27, 2026
PubMed
Summary
This summary is machine-generated.

Selecting the right dialyzer membrane is crucial for effective extracorporeal dialysis. This review proposes a phenotype-based model to individualize membrane selection for better uremic toxin removal and patient outcomes.

Keywords:
dialyzerhemodiafiltrationhemodialysisinflammationresidual kidney function

More Related Videos

Custom-made Microdialysis Probe Design
05:38

Custom-made Microdialysis Probe Design

Published on: July 21, 2015

13.0K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

14.9K

Related Experiment Videos

Last Updated: Apr 28, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K
Custom-made Microdialysis Probe Design
05:38

Custom-made Microdialysis Probe Design

Published on: July 21, 2015

13.0K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

14.9K

Area of Science:

  • Nephrology
  • Biomaterials Science
  • Clinical Medicine

Background:

  • Dialyzers are essential for extracorporeal dialysis, removing uremic toxins and regulating fluids.
  • Dialyzer membranes vary significantly in composition and performance, impacting solute clearance.
  • Current clinical practice often lacks individualized dialyzer membrane selection.

Purpose of the Study:

  • To propose a phenotype-based model for selecting dialyzer membranes in chronic dialysis.
  • To integrate membrane properties with patient-specific factors for optimized therapy.

Main Methods:

  • Review of dialyzer membrane characteristics (polymer chemistry, pore architecture, etc.).
  • Development of a framework linking membrane function to patient phenotypes.
  • Consideration of residual kidney function, nutritional/inflammatory status, cardiovascular physiology, and toxin burden.

Main Results:

  • Distinct membrane families exhibit differential uremic solute clearance capabilities.
  • A phenotype-based model can guide individualized membrane selection.
  • Implementation requires adaptation to local resource availability.

Conclusions:

  • Aligning dialyzer membrane properties with patient-specific toxin profiles is a promising strategy.
  • Individualized membrane selection can optimize extracorporeal therapy.
  • This approach has the potential to improve outcomes in chronic dialysis patients.